VANCOUVER, British Columbia, April 24, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it is working on a research pilot study with Bio Conscious Technologies (BCT) to deliver their artificial intelligence (AI) powered technology to Premier Health’s patient base.
Premier Health is focused on integrating clinical decision support (CDS) tools into their Juno Electronic Medical Records (EMR) software and patient app as a chief ingredient in improving patient care. Once embedded into the Company’s EMR and app, these analytical tools offer a process for enhancing health-related decisions and actions with pertinent, organized clinical knowledge and patient information to improve health and health care delivery. BCT’s proprietary AI technology, the Diabits Prediction Engine, will provide patients and care providers improved monitoring of chronic disease progression and management of chronic conditions, such as diabetes.
The research pilot will use data from patients who are using the app and sign up for the study. The data used will include sugar levels, heart rate, blood pressure, age, sex and weight – much of which is collected from the integration of the patient’s health monitoring devices such as their smartwatch. The Diabits tool will then tailor a personalized blood sugar model which the patient can use to guide their nutrition and exercise plan.
With this collaboration, a diabetic patient’s blood sugar fluctuations, heart rate, and step count will be captured and used to guide behaviour. Using AI, Diabits quickly learns the patient’s unique physiology and predicts when their blood sugar will rise, or fall based on behavioural patterns. Thus, patients can make more informed decisions. By leveraging the monitoring platform, Juno EMR and BCT’s tools, physicians will soon be able to better engage with patients to improve their glucose control and long-term health.
“We are excited to finally be able to utilize data that was previously lost,” said Dr. Essam Hamza, CEO of Premier Health. “We hope to keep patients engaged throughout the day, making them the center of their care. We are confident as we empower patients to regularly use our smart and integrated app, they will have better health outcomes. Our research pilot with BCT is just one of many we have planned in the near future in the hopes of providing leading edge, innovative care to our patients.”
ON BEHALF OF THE BOARD OF DIRECTORS
“Dr. Essam Hamza, MD”
Chief Executive Officer
About Premier Health
Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are focused on innovative health care approaches that combine human skill-based expertise with emerging technologies. Premier Health, in conjunction with its subsidiary Cloud Practice, a cloud-based SAAS Electronic Medical Records software company, is developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI). We currently have a combined ecosystem of 290 clinics, over 3000 licensed practitioners and almost 3 million registered patients. The Premier Health team has deep clinical, operational and financial expertise and a passion for improving healthcare for all patients.
About Bio Conscious Technologies
Bio Conscious Technologies is a health analytics company. Their mission is to enable patients and care providers to better understand and treat diseases using intelligent analytics. Their app, Diabits, allows diabetic users to manage their health without stress. Their multivariate algorithm learns an individual user’s physiology and predicts where their blood sugar will trend over time based on their behavior and activity. With Diabits, users have more glucose control, less Hypo and Hyperglycemia episodes, and better long-term health outcomes.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FOR ADDITIONAL INFORMATION CONTACT:
Premier Health Group Inc.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | email@example.com